SURGALIGN HOLDINGS, INC.: Nasdaq/NYSE listing notice — Surgalign receives Nasdaq delisting notice after Chapter 11 filing; trading to move to OTC

SURGALIGN HOLDINGS, INC.

Nasdaq delisting effective July 3, 2023; Company does not appeal.
Chapter 11 filed June 19, 2023 in Southern District of Texas.
Asset purchase agreement to sell substantially all hardware and biomaterials assets; stalking horse bidder in place for Digital Health.
Common stock expected to trade on OTC under symbol SRGAQ after delisting.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

SURGALIGN HOLDINGS, INC. received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1).

Exchange: nasdaq
Notice: delisting notice
Rules: 5101, 5110(b), IM-5101-1

Exact text from the filing

June 22, 2023, the Company received written notice from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of the Chapter 11 Cases and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, the Staff had determined that the Company’s common stock will be delisted from Nasdaq. The Company does not intend to appeal this determination. Trading of the Company’s common stock will be suspended at the opening of business on July 3, 2023.

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-23-173206

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.